Meeting
2023 ASCO Quality Care Symposium
Tailored doses, tailored savings: Optimizing dosing strategies of immune checkpoint inhibitors.
Authors
Aakash Desai
University of Alabama at Birmingham, Birmingham, AL
Aakash Desai, Chelsee Jensen, Scott A. Soefje, Devika Govind Das, S. M. Qasim Hussaini, Arthi Sridhar
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A
Track
Quality, Safety, and Implementation Science,Cost, Value, and Policy,Patient Experience,Survivorship
Sub Track
Value-Based Models of Care
Citation
JCO Oncol Pract 19, 2023 (suppl 11; abstr 68)
DOI
10.1200/OP.2023.19.11_suppl.68
Abstract #
68
Poster Bd #
C21
Abstract Disclosures
Similar Posters
Poster
2021 Genitourinary Cancers Symposium
Cost-effectiveness analysis of neoadjuvant immune checkpoint inhibition (ICI) versus cisplatin-based chemotherapy (CBC) in muscle-invasive bladder cancer (MIBC).
First Author: Ali Raza Khaki
First Author: Jeddeo Paul
Poster
2024 ASCO Annual Meeting
Cost analysis of targeted and immunotherapies in operable esophageal and non-small cell lung cancers.
First Author: Yahya Alwatari
Poster
2024 ASCO Genitourinary Cancers Symposium
Outcomes of enfortumab vedotin (EV) therapy in relation to prior immune checkpoint inhibitor (ICI) in patients (pts) with advanced urothelial cancer (aUC).
First Author: Evangelia Vlachou